NASDAQ: APGNApexigen Inc Stock Ownership - Who owns Apexigen?
Insider buying vs selling
Have Apexigen Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| William E. Duke | Chief Financial Officer | 2023-05-23 | 17,261 | $0.40 | $6.90kSell |
| Amy Wong | SVP Finance and Operations | 2023-05-23 | 12,234 | $0.40 | $4.89kSell |
| Francis Willard Sarena | President and COO | 2023-05-23 | 20,748 | $0.40 | $8.30kSell |
| Amy Wong | SVP Finance and Operations | 2022-12-15 | 2,851 | $1.06 | $3.02kSell |
| William E. Duke | Chief Financial Officer | 2022-12-15 | 4,503 | $1.06 | $4.77kSell |
| Xiaodong Yang | Chief Executive Officer | 2022-12-15 | 7,001 | $1.06 | $7.42kSell |
| Frank J. Hsu | Chief Medical Officer | 2022-12-15 | 4,323 | $1.06 | $4.58kSell |
| Francis Willard Sarena | Chief Operating Officer | 2022-12-15 | 6,916 | $1.06 | $7.33kSell |
APGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when APGN insiders and whales buy or sell their stock.
APGN Shareholders
What type of owners hold Apexigen Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Decheng Capital Management Iii Cayman LLC | 7.68% | 1,894,551 | $1.02M | Institution |
| Brookline Capital Holdings LLC | 6.60% | 1,627,000 | $878.58k | Insider |
| Xiaodong Yang | 2.15% | 531,391 | $286.95k | Insider |
| Yu Fan 1 | 1.63% | 401,757 | $216.95k | Institution |
| Vanguard Group Inc | 1.04% | 256,935 | $138.74k | Institution |
| Glazer Capital LLC | 0.91% | 225,000 | $121.50k | Insider |
| Blackrock Inc | 0.87% | 213,833 | $115.47k | Institution |
| Geode Capital Management LLC | 0.72% | 178,760 | $96.53k | Institution |
| Francis Willard Sarena | 0.66% | 162,336 | $87.66k | Insider |
| William E. Duke | 0.64% | 158,921 | $85.82k | Insider |
APGN vs Biotech Stocks
Apexigen Stock Ownership FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.